drugset / Trial / NCT00420823
A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment
Phase 2/3
Completed
121 enrolled
Melbourne Health
Southern Health · collabStanley Medical Research Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Taurine 4g is effective with antipsychotic medication in the treatment of First Episode Psychosis.Taurine may have an effect on cognition and symptoms. We are examining changes in symptoms and cognition over a 3 month period.
Timeline
- Start
- 2007-01
- Primary completion
- 2009-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Taurine | Other / unclassified | 4 g | — |